Chris Boshoff, the head of Pfizer’s cancer R&D unit, will become the pharma giant’s new chief scientific officer and president of R&D on Jan. 1 …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The Chemilogics platform benefits from a wealth of clinical data, and recent advances in genomics, AI and synthetic biology. Source: Shutterstock / metamorworks Life sciences
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Henry Schein said Wednesday it
DiaCarta, Inc., a pioneer in molecular diagnostic test development for cancer and infectious diseases, based in California, today announced that it has established a strategic